|
1.
|
|
|
2.
|
|
9 p, 474.5 KB |
Clinical and functional characteristics, possible causes, and impact of chronic cough in patients with cerebellar ataxia, neuropathy, and bilateral vestibular areflexia syndrome (CANVAS)
/
Palones, Esther (Institut d'Investigació Biomèdica Sant Pau) ;
Curto Sánchez, Elena (Institut d'Investigació Biomèdica Sant Pau) ;
Plaza, Vicente (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Gonzalez-Quereda, L (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Segarra Casas, Alba (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Querol, Luis (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Bertoletti, Federico (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Rodriguez, María José (Institut d'Investigació Biomèdica Sant Pau) ;
Gallano, Pía (Institut d'Investigació Biomèdica Sant Pau) ;
Crespo Lessmann, Astrid (Universitat Autònoma de Barcelona. Departament de Medicina)
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) is an hereditary autosomal recessive disease. Recent studies propose including chronic cough (CC) as a symptom of CANVAS. [...]
2023 -  10.1007/s00415-023-12001-9
Journal of Neurology, 2023
|
|
|
3.
|
|
7 p, 817.8 KB |
Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis : results from the HEBEM study
/
Marzo Escartin, Blanca (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron) ;
Castilló, Joaquín (Hospital Universitari Vall d'Hebron) ;
Robles-Sanchez, Miguel-Angel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Otero-Romero, Susana (Hospital Universitari Vall d'Hebron) ;
Tintoré, Mar (Hospital Universitari Vall d'Hebron) ;
Montalban, Xavier (Hospital Universitari Vall d'Hebron) ;
Buti, Maria (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Riveiro Barciela, Mar (Universitat Autònoma de Barcelona. Departament de Medicina)
INTRODUCTION: Prospective data on the risk of hepatitis B reactivation (HBVr) among patients with resolved HBV infection undergoing anti-CD20 antibodies monotherapy is scarce. We aimed to assess the risk of HBVr in patients with resolved HBV infection treated with rituximab or ocrelizumab in monotherapy for multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) without antiviral prophylaxis. [...]
D. Steinkopff-Verlag, 2023 - 10.1007/s00415-023-11973-y
Journal of Neurology, Vol. 271 (2024) p. 134-140
|
|
|
4.
|
|
10 p, 876.7 KB |
Measuring cognitive impairment and monitoring cognitive decline in Huntington's disease : a comparison of assessment instruments
/
Horta, Andrea (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Martinez-Horta, Saul (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Pérez-Pérez, Jesús (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Puig-Davi, Arnau (Institut d'Investigació Biomèdica Sant Pau) ;
de Lucia, Natascia (University of Naples "Federico II", Naples, Italy) ;
de Michele, Giuseppe (University of Naples "Federico II", Naples, Italy) ;
Salvatore, Elena (University of Naples "Federico II", Naples, Italy) ;
Kehrer, Stefanie (Charité-Universitätsmedizin, Berlin, Germany) ;
Priller, Josef (Charité-Universitätsmedizin, Berlin, Germany) ;
Migliore, Simone (Fondazione IRCCS Casa Sollievo Della Sofferenza Research Hospital, San Giovanni Rotondo, Italy) ;
Squitieri, Ferdinando (Fondazione IRCCS Casa Sollievo Della Sofferenza Research Hospital, San Giovanni Rotondo, Italy) ;
Castaldo, Ana (Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy) ;
Mariotti, Caterina (Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy) ;
Mañanes, Verónica (Hospital Universitario Ramon Y Cajal) ;
Lopez-Sendon, José Luís (Hospital Universitario Ramon Y Cajal) ;
Rodriguez, Noelia (Fundación Jimenez Diaz) ;
Martinez-Descals, Asunción (Fundación Jimenez Diaz) ;
Júlio, Filipa (Coimbra University Hospital) ;
Januário, Cristina (Coimbra University Hospital) ;
Delussi, marianna (European Huntington's Disease Network (EHDN), Ulm, Germany) ;
de Tommaso, Marina (European Huntington's Disease Network (EHDN), Ulm, Germany) ;
Noguera, Sandra (Hospital Mare de Deu de La Mercè) ;
Ruiz-Idiago, Jesús (Hospital Mare de Deu de La Mercè) ;
Sitek, Emilia J. (St. Adalbert Hospital, Copernicus, Gdańsk, Poland) ;
Wallner, Renata (Medical University of Wroclaw, Wroclaw, Poland) ;
Nuzzi, Angela (European Huntington's Disease Network (EHDN), Ulm, Germany) ;
Pagonabarraga Mora, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Kulisevsky, Jaime (Universitat Autònoma de Barcelona. Departament de Medicina)
Background: Progressive cognitive decline is an inevitable feature of Huntington's disease (HD) but specific criteria and instruments are still insufficiently developed to reliably classify patients into categories of cognitive severity and to monitor the progression of cognitive impairment. [...]
2023 - 10.1007/s00415-023-11804-0
Journal of Neurology, Vol. 270, Num. 11 (november 2023) , p. 5408-5417
|
|
|
5.
|
|
12 p, 2.9 MB |
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1) : Refining muscle involvement and implications for clinical trials
/
Garibaldi, Matteo (Sant'Andrea Hospital) ;
Nicoletti, Tommaso (Università Cattolica del Sacro Cuore) ;
Bucci, Elisabetta (Sant'Andrea Hospital) ;
Fionda, Laura (Sant'Andrea Hospital. Sapienza University of Rome) ;
Leonardi, Luca (Sant'Andrea Hospital) ;
Morino, Stefania (Sant'Andrea Hospital) ;
Tufano, Laura (Sant'Andrea Hospital) ;
Alfieri, Girolamo (Sant'Andrea Hospital) ;
Lauletta, Antonio (Sant'Andrea Hospital) ;
Merlonghi, Gioia (Sant'Andrea Hospital) ;
Perna, Alessia (Università Cattolica del Sacro Cuore) ;
Rossi, Salvatore (Università Cattolica del Sacro Cuore) ;
Ricci, Enzo (Università Cattolica del Sacro Cuore) ;
Alonso-Pérez, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Tartaglione, Tommaso (Istituto Dermopatico dell'Immacolata) ;
Petrucci, Antonio (San Camillo Forlanini Hospital) ;
Pennisi, Elena Maria (San Filippo Neri Hospital) ;
Salvetti, Marco (IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed) ;
Cutter, Gary (University of Alabama at Birmingham) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Silvestri, Gabriella (Università Cattolica del Sacro Cuore) ;
Antonini, Giovanni (Sant'Andrea Hospital)
Only a few studies have reported muscle imaging data on small cohorts of patients with myotonic dystrophy type 1 (DM1). We aimed to investigate the muscle involvement in a large cohort of patients in order to refine the pattern of muscle involvement, to better understand the pathophysiological mechanisms of muscle weakness, and to identify potential imaging biomarkers for disease activity and severity. [...]
2021 - 10.1111/ene.15174
European Journal of Neurology, Vol. 29 (december 2021) , p. 843-854
|
|
|
6.
|
|
9 p, 1.1 MB |
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function
/
Lehmann, Sylvain (IRMB CHU de Montpellier) ;
Schraen-Maschke, Susanna (CHU Lille) ;
Vidal, Jean-Sébastien (APHP) ;
Delaby, Constance (Institut d'Investigació Biomèdica Sant Pau) ;
Blanc, Frédéric (University Hospital of Strasbourg) ;
Paquet, Claire (Centre de Neurologie Cognitive) ;
Allinquant, Bernadette (Inserm) ;
Bombois, Stéphanie (GH Pitié-Salpêtrière) ;
Gabelle, Audrey (Inserm INM) ;
Hanon, Olivier (APHP) ;
Universitat Autònoma de Barcelona
Plasma P-tau181 is an increasingly established diagnostic marker for Alzheimer's disease (AD). Further validation in prospective cohorts is still needed, as well as the study of confounding factors that could influence its blood level. [...]
2023 - 10.1136/jnnp-2022-330540
Journal of Neurology, Neurosurgery, and Psychiatry, Vol. 94 (april 2023) , p. 411-419
|
|
|
7.
|
|
13 p, 3.4 MB |
Muscle MRI characteristic pattern for late-onset TK2 deficiency diagnosis
/
Domínguez-González, Cristina (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Fernández-Torrón, Roberto (Servicio de Neurología. Instituto de Investigación Sanitaria Biodonostia. Área neuromuscular. Hospital Donostia. Servicio Vasco de Salud) ;
Moore, Ursula (John Walton Muscular Dystrophy Research Center. University of Newcastle) ;
de Fuenmayor-Fernández de la Hoz, Carlos Pablo (Hospital Universitario 12 de Octubre (Madrid). Servicio de Neurología) ;
Vélez-Gómez, Beatriz (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Cabezas, Juan Antonio (Hospital Universitario Virgen del Rocío. Unidad de Enfermedades Neuromusculares. Servicio de Neurología. Instituto de Biomedicina de Sevilla) ;
Alonso-Pérez, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
González-Mera, Laura (Institut d'Investigació Biomèdica de Bellvitge) ;
Olive, Montse (Institut d'Investigació Biomèdica Sant Pau) ;
García-García, Jorge (Hospital Universitario de Albacete. Departamento de Neurología) ;
Morís, Germán (Hospital Universitario Central de Asturias) ;
León Hernández, Juan Carlos (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife)) ;
Muelas, Nuria (Instituto de Investigación Sanitaria La Fe) ;
Servian-Morilla, Emilia (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Martin, Miguel A. (Hospital Universitario 12 de Octubre (Madrid)) ;
Diaz-Manera, Jordi (John Walton Muscular Dystrophy Research Centre Newcastle University Translational and Clinical Research Institute Central Parkway) ;
Paradas, Carmen (Instituto de Biomedicina de Sevilla) ;
Universitat Autònoma de Barcelona
Background and objective: TK2 deficiency (TK2d) is a rare mitochondrial disorder that manifests predominantly as a progressive myopathy with a broad spectrum of severity and age of onset. The rate of progression is variable, and the prognosis is poor due to early and severe respiratory involvement. [...]
2022 - 10.1007/s00415-021-10957-0
Journal of Neurology, Vol. 269 Núm. 7 (july 2022) , p. 3550-3562
|
|
|
8.
|
|
10 p, 709.5 KB |
Post-COVID-19 fatigue : the contribution of cognitive and neuropsychiatric symptoms
/
Calabria, Marco (Universitat Oberta de Catalunya. Estudis de Ciències de la Salut) ;
García-Sánchez, Carmen (Institut d'Investigació Biomèdica Sant Pau) ;
Grunden, Nicholas (Centre for Research On Brain. Language & Music) ;
Pons, Catalina (Universitat Ramon Llull. Facultat de Psicologia, Ciències de l'Educació i l'Esport. Blanquerna.) ;
Arroyo, Juan Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Gómez-Ansón, Beatriz (Institut d'Investigació Biomèdica Sant Pau) ;
Estévez García, Marina del Carmen (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Belvís, Roberto (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Morollón, Noemí (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Vera Igual, Javier (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Mur, Isabel (Institut d'Investigació Biomèdica Sant Pau) ;
Pomar, Virginia (Institut d'Investigació Biomèdica Sant Pau) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Fatigue in its many forms of physical, mental, and psychosocial exhaustion is a common symptom of post-COVID-19 condition, also known as "Long COVID. " Persistent fatigue in COVID-19 patients is frequently accompanied by cognitive dysfunction and neuropsychiatric symptoms; however, less is known about the relationships between these components of post-COVID-19 condition and fatigue itself. [...]
2022 - 10.1007/s00415-022-11141-8
Journal of Neurology, Vol. 269 Núm. 8 (august 2022) , p. 3990-3999
|
|
|
9.
|
|
14 p, 1.0 MB |
Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis : 6-year results from the SELECTED open-label extension study
/
Gold, Ralf (Ruhr-University Bochum) ;
Radue, Ernst-Wilhem (University Hospital Basel (Basilea, Suïssa)) ;
Giovannoni, Gavin (Queen Mary University of London) ;
Selmaj, Krzysztof. (University of Warmia and Mazury) ;
Havrdova, Eva Kubala (Charles University) ;
Montalban, Xavier (Hospital Universitari Vall d'Hebron) ;
Stefoski, Dusan (Rush University Medical Center) ;
Sprenger, Till (DKD Helios Klinik Wiesbaden) ;
Robinson, Randy R. (AbbVie Inc.) ;
Fam, Sami (Biogen) ;
Smith, Jonathan (Biogen) ;
Chalkias, Spyros (Biogen) ;
Giannattasio, Giorgio (Biogen) ;
Lima, Gabriel (Biogen) ;
Castro-Borrero, Wanda (Biogen) ;
Universitat Autònoma de Barcelona
Objective: SELECTED, an open-label extension study, evaluated daclizumab beta treatment for up to 6 years in participants with relapsing multiple sclerosis who completed the randomized SELECT/SELECTION studies. [...]
2020 - 10.1007/s00415-020-09835-y
Journal of Neurology, Vol. 267 Núm. 10 (january 2020) , p. 2851-2864
|
|
|
10.
|
|
12 p, 888.5 KB |
Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
/
Turner, Benjamin (The Royal London Hospital) ;
Cree, Bruce A. C (University of California) ;
Kappos, Ludwig (University Hospital Basel (Basilea, Suïssa)) ;
Montalban, Xavier (Hospital Universitari Vall d'Hebron) ;
Papeix, Caroline (Pitié-Salpêtrière Hospital) ;
Wolinsky, Jerry S. (The University of Texas Health Science Center at Houston (UTHealth)) ;
Buffels, Regine (F. Hoffmann-La Roche Ltd) ;
Fiore, Damian (Genentech. Inc) ;
Garren, Hideki (Genentech. Inc) ;
Han, Jian (Genentech. Inc) ;
Hauser, Stephen L. (University of California) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Objective: The efficacy and safety of ocrelizumab, versus interferon (IFN) β-1a, for the treatment of relapsing multiple sclerosis (RMS) from the identically designed OPERA I (NCT01247324) and OPERA II (NCT01412333) phase III studies has been reported; here we present subgroup analyses of efficacy endpoints from the pooled OPERA I and OPERA II populations. [...]
2019 - 10.1007/s00415-019-09248-6
Journal of Neurology, Vol. 266 Núm. 5 (may 2019) , p. 1182-1193
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
